Intelligent Bio Solutions

Intelligent Bio Solutions ROCE

The Return on Capital Employed (ROCE) of Intelligent Bio Solutions (INBS) as of Oct 22, 2026 is -238.30 %. In the previous year, Return on Capital Employed (ROCE) was -378.30 % — a change of -37.01% (higher).

ROCE

-238.30 %

YoY

-37.01%

Last updated:

In 2026, Intelligent Bio Solutions's return on capital employed (ROCE) was -238.30 %, a -37.01% increase from the -378.30 % ROCE in the previous year.

The Intelligent Bio Solutions ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
169.21 USD
Jan 1, 2020
51.89 USD
Jan 1, 2021
-46.89 USD
Jan 1, 2022
-127.36 USD
Jan 1, 2023
-341.61 USD
Jan 1, 2024
-125.66 USD
Jan 1, 2025
-378.30 USD
Jan 1, 2026
-238.30 USD
The Intelligent Bio Solutions ROCE history
YEARROCEYoY
-238.30 %-37.01%
-378.30 %+201.04%
-125.66 %-63.21%
-341.61 %+168.22%
-127.36 %+171.61%
-46.89 %-190.36%
51.89 %-69.33%
169.21 %+12.62%
150.24 %+5,034.77%
2.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligent Bio Solutions Stock analysis

What does Intelligent Bio Solutions do? Intelligent Bio Solutions, Inc. generates revenue through its Commercially available Intelligent Fingerprinting Products (IFPG) segment, which includes a portable drug screening system analyzing fingerprint sweat via a one-time cartridge and handheld reader. The company also develops diagnostic tests under the Development Stage Saliva Glucose Biosensor Platform (SGBP), targeting diabetic patients with a non-invasive saliva glucose biosensor (SGB) intended to replace finger-prick blood monitoring. Its biosensor platform supports multiple biological analyte detection for point-of-care diagnostic tests (POCT) in clinical chemistry, immunology, tumor markers, allergens, and endocrinology. The firm serves primary health practitioners and patients seeking non-invasive monitoring solutions. The company's product portfolio features the IFPG segment's portable drug screening system, which is sold to healthcare providers and law enforcement agencies for rapid drug testing. The SGBP segment focuses on developing the Saliva Glucose Biosensor (SGB), a point-of-care diagnostic test expected to address the needs of diabetic patients requiring frequent glucose monitoring without invasive procedures. The biosensor platform enables detection of multiple analytes, expanding the company's offerings in clinical chemistry and related diagnostic fields. Intelligent Bio Solutions, Inc. targets primary health practitioners and patients as key segments for its non-invasive diagnostic solutions. The IFPG segment's portable drug screening system is designed for use in clinical and law enforcement settings, while the SGBP segment's Saliva Glucose Biosensor aims to provide a convenient alternative to traditional blood glucose monitoring for diabetic patients. The company's development stage products focus on replacing invasive methods with real-time, non-invasive monitoring technologies. Intelligent Bio Solutions is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Intelligent Bio Solutions's Return on Capital Employed (ROCE)

Intelligent Bio Solutions's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Intelligent Bio Solutions's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Intelligent Bio Solutions's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Intelligent Bio Solutions’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Intelligent Bio Solutions stock

Return on Capital Employed (ROCE) of Intelligent Bio Solutions is -238.30 % in 2026.

Return on Capital Employed (ROCE) of Intelligent Bio Solutions changed from -378.30 % to -238.30 %, representing a -37.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Intelligent Bio Solutions since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Intelligent Bio Solutions with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Intelligent Bio Solutions

All Key Metrics — Intelligent Bio Solutions